Key Points (from the article):
- Multiple sclerosis (MS) is a variable lifelong condition. There are several disease patterns, and these clinical sub-types may alter in an individual over time.
- The severity of the condition, in terms of relapse frequency, degree of visability and level of symptoms varies within and between individuals.
- The treatment of MS is aimed at symptoms, relapse and clinical course.
- Steroids are the only drugs shown to be of benefit in acute relapse.
- Beta Interferons, glatarimer acetate, some monoclonal antibodies against adhesion molecules and some chemotherapeutic agents have been shown to alter disease course.
- Future treatments which have not yet been evaluated may include neural growth factors and stem cell therapy.
Team Neurology4MRCP
